This actress fell in depression after many called her a 'drug addict'. The situation went out of hands when her mother had ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The synergistic relationship between psychiatric medications and psychotherapy is often overlooked. By managing discreet ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

The world’s largest genetic study into depression has uncovered life-changing discoveries that will revolutionise treatments ...

which aims to reduce the overprescribing of drugs, said family doctors were being left to deal “with a huge amount of depression”. The proposals, drawn up in collaboration with Dr Peter ...